BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2245983)

  • 1. Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet.
    Roth AC; Milsom I; Forssman L; Wåhlén P
    Genitourin Med; 1990 Oct; 66(5):357-60. PubMed ID: 2245983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A multicenter, randomized, open and positive parallel controlled clinical study of clotrimazole vaginal expansion suppository and vaginal tablet in the treatment of mild and moderate vulvovaginal candidiasis].
    Zhang L; Liao QP; Wang CH; Zhang D; An RF; Zheng JH; Wang Y; Zhang QQ; Chen R
    Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):697-702. PubMed ID: 33120482
    [No Abstract]   [Full Text] [Related]  

  • 3. Intermittent local prophylaxis against recurrent vaginal candidosis.
    Bushell TE; Evans EG; Meaden JD; Milne JD; Warnock DW
    Genitourin Med; 1988 Oct; 64(5):335-8. PubMed ID: 3060424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clotrimazole treatment of recurrent and chronic candida vulvovaginitis.
    Sobel JD; Schmitt C; Meriwether C
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):330-4. PubMed ID: 2644595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a vaginal suppository formulation of dill (Anethum graveolens) in comparison to clotrimazole vaginal tablet on the treatment of vulvovaginal candidiasis.
    Saghafi N; Karjalian M; Ghazanfarpour M; Khorsand I; Rakhshandeh H; Mirteimouri M; Babakhanian M; Khadivzadeh T; Najafzadeh MJ; Ghorbani A; Pourali L; Bahman S
    J Obstet Gynaecol; 2018 Oct; 38(7):985-988. PubMed ID: 29553834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of prophylactic (monthly) clotrimazole versus empiric self-treatment in recurrent vaginal candidiasis.
    Fong IW
    Genitourin Med; 1994 Apr; 70(2):124-6. PubMed ID: 8206471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent genital candidosis in women and the effect of intermittent prophylactic treatment.
    Davidson F; Mould RF
    Br J Vener Dis; 1978 Jun; 54(3):176-83. PubMed ID: 26452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the effectiveness of Salvia officinalis, clotrimazole and their combination on vulvovaginal candidiasis: A randomized, controlled clinical trial.
    Ahangari F; Farshbaf-Khalili A; Javadzadeh Y; Adibpour M; Sadeghzadeh Oskouei B
    J Obstet Gynaecol Res; 2019 Apr; 45(4):897-907. PubMed ID: 30663184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of terconazole and clotrimazole vaginal tablets in the treatment of vulvovaginal candidosis.
    Kjaeldgaard A
    Pharmatherapeutica; 1986; 4(8):525-31. PubMed ID: 3520601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose 500-mg clotrimazole vaginal tablets compared with placebo in the treatment of Candida vaginitis.
    Bro F
    J Fam Pract; 1990 Aug; 31(2):148-52. PubMed ID: 2199599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind evaluation of miconazole tampons, compared with clotrimazole vaginal tablets, in vaginal candidiasis.
    Lolis D; Kanellopoulos N; Liappas I; Xyngakis A; Zissis NP
    Clin Ther; 1981; 4(3):212-6. PubMed ID: 7307036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-day treatment of vulvovaginal candidiasis with a 500-mg clotrimazole vaginal tablet compared with a three-day regimen of two 100-mg vaginal tablets daily.
    Floyd R; Hodgson C
    Clin Ther; 1986; 8(2):181-6. PubMed ID: 3698065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study.
    De Seta F; Parazzini F; De Leo R; Banco R; Maso GP; De Santo D; Sartore A; Stabile G; Inglese S; Tonon M; Restaino S
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():136-9. PubMed ID: 25305660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of vulvovaginal candidiasis with a 500-mg vaginal tablet of clotrimazole.
    Hughes D; Kriedman T
    Clin Ther; 1984; 6(5):662-8. PubMed ID: 6383612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis.
    Fong IW
    Genitourin Med; 1992 Dec; 68(6):374-7. PubMed ID: 1336762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of clotrimazole vaginal tablet vs. oral fluconazole in treating severe vulvovaginal candidiasis.
    Zhou X; Li T; Fan S; Zhu Y; Liu X; Guo X; Liang Y
    Mycoses; 2016 Jul; 59(7):419-28. PubMed ID: 27073145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the efficacy of two vaginal creams for vulvovaginal candidiasis, and correlations with the presence of Candida species in the perianal area and oral contraceptive use.
    Lebherz TB; Goldman L; Wiesmeier E; Mason D; Ford LC
    Clin Ther; 1983; 5(4):409-16. PubMed ID: 6347382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal secretion levels after 6 days, 3 days and 1 day of treatment with 100, 200 and 500 mg vaginal tablets of clotrimazole and their therapeutic efficacy.
    Mendling W; Plempel M
    Chemotherapy; 1982; 28 Suppl 1():43-7. PubMed ID: 7160240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative clinical trial of fenticonazole ovule (600 mg) versus clotrimazole vaginal tablet (500 mg) in the treatment of symptomatic vaginal candidiasis.
    Studd JW; Dooley MM; Welch CC; Vijayakanthan K; Mowat JM; Wade A; Newell M
    Curr Med Res Opin; 1989; 11(8):477-84. PubMed ID: 2680285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic results obtained in vaginal mycoses after single-dose treatment with 500 mg clotrimazole vaginal tablets.
    Fleury F; Hughes D; Floyd R
    Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 2):968-70. PubMed ID: 3895963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.